Skip to main content
Log in

Barrett’s Oesophagus

A Review of Costs of the Illness

  • Review Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Barrett’s oesophagus is a premalignant complication that occurs in approximately 10% of patients with gastro-oesophageal reflux disease (GORD). In patients with Barrett’s oesophagus, the risk of adenocarcinoma of the oesophagus approaches 0.5% per patient-years. Therefore, practice guidelines have been developed that suggest screening patients with GORD, particularly those with long-standing symptoms and those aged ≥50 years for the presence of Barrett’s metaplasia. These guidelines also suggest performing surveillance endoscopy for the development of dysplasia and/or cancer in patients found to harbour Barrett’s oesophagus at initial screening with the frequency of subsequent endoscopies dictated by the presence and grade of dysplasia. In patients with high-grade dysplasia and/or early adenocarcinoma, oesophagectomy is curative.

Given the important clinical and economic implications of GORD complicated by Barrett’s oesophagus, we review the costs associated with screening, surveillance and treatment for this condition. Although the majority of physicians recommend and/or perform surveillance for dysplasia in the setting of Barrett’s oesophagus, differences in endoscopic technique, surveillance intervals and cancer perception among practitioners influence total costs. In the US, it is estimated that a population-wide surveillance program could potentially result in a total cost of $US289.9 million. The outpatient management of Barrett’s oesophagus is estimated to cost $US1241 per year with medication use alone accounting for over half of the total costs. Cost-effectiveness analyses have been performed to evaluate the economic impact and benefit of surveillance for dysplasia and/or cancer. Studies to date have utilised several outcome measures such as life-years gained, quality-adjusted life-years and cases of cancer detected. Therefore, the incremental cost-effectiveness ratios reported have varied greatly and are particularly sensitive to the prevalence of Barrett’s oesophagus in patients with GORD and the incidence of adenocarcinoma. Further epidemiological and clinical studies are likely to further define the economic impact of Barrett’s oesophagus as a complication of GORD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Spechler SJ, Goyal RK. Barrett’s esophagus. N Engl J Med 1986; 315: 362–71

    Article  PubMed  CAS  Google Scholar 

  2. Winters CJ, Spurling TJ, Chobanian SJ, et al. Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;: 118–24

  3. Spechler SJ. Barrett’s esophagus: what’s new and what to do. Am J Gastroenterol 1989; 84: 220–3

    PubMed  CAS  Google Scholar 

  4. Provenzale D, Schmitt C, Wong JB, et al. Barrett’s esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94: 2043–53

    Article  PubMed  CAS  Google Scholar 

  5. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–9

    Article  PubMed  CAS  Google Scholar 

  6. Blot WJ, Devesa SS, Fraumeni JF, et al. Continuing climb in rates of esophageal adenocarcinoma: an update [letter]. JAMA 1993; 270: 1320

    Article  PubMed  CAS  Google Scholar 

  7. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825–31

    Article  PubMed  CAS  Google Scholar 

  8. Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 1998; 93: 1028–32

    Article  PubMed  CAS  Google Scholar 

  9. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus. Am J Gastroenterol 1988; 83: 291–4

    PubMed  CAS  Google Scholar 

  10. Provenzale D, Kemp JA, Arora S, et al. A guide for surveillance of patients with Barrett’s esophagus. Am J Gastroenterol 1994; 89: 670–80

    PubMed  CAS  Google Scholar 

  11. Falk GW, Ours TM, Richter JE, et al. Practice patterns for surveillance of Barrett’s esophagus in the United States. Gastrointest Endosc 2000; 52: 197–203

    Article  PubMed  CAS  Google Scholar 

  12. Gross CP, Canto MI, Hixson J, et al. Management of Barrett’s esophagus: a national study of practice patterns and their cost implications. Am J Gastroenterol 1999; 94: 3440–7

    Article  PubMed  CAS  Google Scholar 

  13. Cruz-Corea M, Gross CP, Canto MI, et al. The impact of practice guidelines on management of Barrett’s esophagus: a prospective cohort [abstract]. Am J Gastroenterol 2000; 95: 2627

    Article  Google Scholar 

  14. Van Sandick J, Bartelsman JM, van Lanschot JJ, et al. Surveillance of Barrett’s oesophagus: physicians’ practices and review of current guidelines. Eur J Gastroenterol Hepatol 2000; 12: 111–7

    PubMed  Google Scholar 

  15. Smith AM, Maxwell-Armstrong CA, Welch NT, et al. Surveillance for Barrett’s oesophagus in the UK. Br J Surg 1999; 86: 276–80

    Article  PubMed  CAS  Google Scholar 

  16. Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448–56

    Article  PubMed  Google Scholar 

  17. Levin T, Schmittdiel J, Kunz K, et al. Costs of acid related disorders to a health maintenance organization. Am J Med 1997; 103: 520–8

    Article  PubMed  CAS  Google Scholar 

  18. Eloubeidi MA, Homan RK, Martz MD, et al. A cost analysis of outpatient care for patients with Barrett’s esophagus in a managed care setting. Am J Gastroenterol 1999; 94: 2033–6

    Article  PubMed  CAS  Google Scholar 

  19. Soni A, Sampliner RE, Sonnenberg A, et al. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective? Am J Gastroenterol 2000; 95: 2086–93

    Article  PubMed  CAS  Google Scholar 

  20. Heudebert G, Centor R, Marks R, et al. Endoscopy in chronic heartburn to screen for Barrett’s esophagus (BE): can we really afford it? [abstract]. Am J Gastroenterol 1998; 93: 1614

    Google Scholar 

  21. Wright TA, Gray MR, Morris AI, et al. Cost effectiveness of detecting Barrett’s cancer. Gut 1996; 39: 574–9

    Article  PubMed  CAS  Google Scholar 

  22. Streitz JMJ, Ellis FHJ, Tilden RL, et al. Endoscopic surveillance of Barrett’s esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol 1998; 93: 911–5

    Article  PubMed  Google Scholar 

  23. Ofman JJ, Lewin K, Ramers C, et al. The economic impact of the diagnosis of dysplasia in Barrett’s esophagus. Am J Gastroenterol 2000; 95: 2946–52

    Article  PubMed  CAS  Google Scholar 

  24. Osgard EM, Hirota WK, Maydonovitch CL, et al. A comparison of screening strategies to diagnose Barrett’s esophagus [abstract]. Gastroenterology 2000; 116: AB: G 1200

    Google Scholar 

  25. Shaheen NJ, Crosby MA, Bozymski EM, et al. Is there publication bias in the reporting of cancer risk in Barrett’s esophagus? Gastroenterology 2000; 119: 333–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamad A. Eloubeidi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arguedas, M.R., Eloubeidi, M.A. Barrett’s Oesophagus. Pharmacoeconomics 19, 1003–1011 (2001). https://doi.org/10.2165/00019053-200119100-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-200119100-00003

Keywords

Navigation